Victor is the VP of Strategy & Operations at Resolution Therapeutics. Victor began his life sciences career as a Venture Fellow at Flagship Pioneering in 2012, after which he founded Desktop Genetics, a genome editing bioinformatics and AI company. Victor led the company through multiple financing rounds, industrial partnerships, product launches and ultimately the sale of the company in 2018. In 2019, Victor joined medical technology company Owkin where he supported the growth of the company through to Series B as VP, Head of Commercial Operations. Victor holds an MEng in chemical engineering from Imperial College London and an MPhil in Bioscience Enterprise from the University of Cambridge. Victor was nominated 30 Under 30 by Forbes, and MIT Innovator Under 35, Entrepreneur of the Year 2017 by the MIT Technology Review.